TrialBreast cancer research and treatment2018

Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.

Alexios Matikas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.